The phenotype of AI SCD in children was described as benign and was attributed to their high fetalhaemoglobin (HbF).
2
These data indicate a possible effect of insulin-treatment on delaying transition from fetal to adult haemoglobin synthesis or on reactivation of fetalhaemoglobin production.
3
The latter TNE is an alternative strategy to ameliorate the clinical manifestations of sickle cell anaemia by re-activating fetalhaemoglobin gene expression in adult erythrocytes.
4
In children aged over 6 years, elevated fetalhaemoglobin levels were measured in 13 diabetic patients (13.3%) in contrast to none of the control group.
5
Fetalhaemoglobin levels were measured in 106 patients with Type 1 (insulin-dependent) diabetes mellitus during a period of two to three years.